These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29701772)

  • 21. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores.
    Jungbluth H; Müller CR; Halliger-Keller B; Brockington M; Brown SC; Feng L; Chattopadhyay A; Mercuri E; Manzur AY; Ferreiro A; Laing NG; Davis MR; Roper HP; Dubowitz V; Bydder G; Sewry CA; Muntoni F
    Neurology; 2002 Jul; 59(2):284-7. PubMed ID: 12136074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
    Garibaldi M; Rendu J; Brocard J; Lacene E; Fauré J; Brochier G; Beuvin M; Labasse C; Madelaine A; Malfatti E; Bevilacqua JA; Lubieniecki F; Monges S; Taratuto AL; Laporte J; Marty I; Antonini G; Romero NB
    Acta Neuropathol Commun; 2019 Jan; 7(1):3. PubMed ID: 30611313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Zhou H; Lillis S; Loy RE; Ghassemi F; Rose MR; Norwood F; Mills K; Al-Sarraj S; Lane RJ; Feng L; Matthews E; Sewry CA; Abbs S; Buk S; Hanna M; Treves S; Dirksen RT; Meissner G; Muntoni F; Jungbluth H
    Neuromuscul Disord; 2010 Mar; 20(3):166-73. PubMed ID: 20080402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling.
    Zhou H; Rokach O; Feng L; Munteanu I; Mamchaoui K; Wilmshurst JM; Sewry C; Manzur AY; Pillay K; Mouly V; Duchen M; Jungbluth H; Treves S; Muntoni F
    Hum Mutat; 2013 Jul; 34(7):986-96. PubMed ID: 23553787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and cellular localization of a modified type 1 ryanodine receptor and L-type channel proteins in non-muscle cells.
    Lee BS; Sessanna S; Laychock SG; Rubin RP
    J Membr Biol; 2002 Oct; 189(3):181-90. PubMed ID: 12395283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ryanodine receptor defects in muscle genetic diseases.
    Brini M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1245-55. PubMed ID: 15336972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells.
    Greer LK; Meilleur KG; Harvey BK; Wires ES
    Orphanet J Rare Dis; 2022 Jun; 17(1):225. PubMed ID: 35698232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.
    D'Adamo MC; Sforna L; Visentin S; Grottesi A; Servettini L; Guglielmi L; Macchioni L; Saredi S; Curcio M; De Nuccio C; Hasan S; Corazzi L; Franciolini F; Mora M; Catacuzzeno L; Pessia M
    PLoS One; 2016; 11(5):e0155516. PubMed ID: 27196359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes.
    Avila G; Lee EH; Perez CF; Allen PD; Dirksen RT
    J Biol Chem; 2003 Jun; 278(25):22600-8. PubMed ID: 12704193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mini-dystrophin expression down-regulates overactivation of G protein-mediated IP3 signaling pathway in dystrophin-deficient muscle cells.
    Balghi H; Sebille S; Constantin B; Patri S; Thoreau V; Mondin L; Mok E; Kitzis A; Raymond G; Cognard C
    J Gen Physiol; 2006 Feb; 127(2):171-82. PubMed ID: 16446505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells.
    Valdés JA; Gaggero E; Hidalgo J; Leal N; Jaimovich E; Carrasco MA
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C715-25. PubMed ID: 18184878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands.
    Jungbluth H; Beggs A; Bönnemann C; Bushby K; Ceuterick-de Groote C; Estournet-Mathiaud B; Goemans N; Guicheney P; Lescure A; Lunardi J; Muntoni F; Quinlivan R; Sewry C; Straub V; Treves S; Ferreiro A
    Neuromuscul Disord; 2004 Nov; 14(11):754-66. PubMed ID: 15482962
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes.
    Eltit JM; Yang T; Li H; Molinski TF; Pessah IN; Allen PD; Lopez JR
    J Biol Chem; 2010 Apr; 285(18):13781-7. PubMed ID: 20207743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
    Treves S; Jungbluth H; Muntoni F; Zorzato F
    Curr Opin Pharmacol; 2008 Jun; 8(3):319-26. PubMed ID: 18313359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmin mutations result in mitochondrial dysfunction regardless of their aggregation properties.
    Smolina N; Khudiakov A; Knyazeva A; Zlotina A; Sukhareva K; Kondratov K; Gogvadze V; Zhivotovsky B; Sejersen T; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165745. PubMed ID: 32105824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors.
    Ruiz A; Benucci S; Duthaler U; Bachmann C; Franchini M; Noreen F; Pietrangelo L; Protasi F; Treves S; Zorzato F
    Elife; 2022 Mar; 11():. PubMed ID: 35238775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.